COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 2826: Articles 28251-28260  | Next

COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
Vuagnat, P., Frelaut, M., Ramtohul, T., Basse, C., Diakite, S., Noret, A., Bellesoeur, A., Servois, V., Hequet, D., Laas, E., Kirova, Y., Cabel, L., Pierga, J.-Y., Institut Curie Breast Cancer and COVID Group, , Bozec, L., Paoletti, X., Cottu, P., Bidard, F.-C.
10.1101/2020.04.30.20085928 — Posted: 2020-05-05
Public knowledge, attitudes and practices towards COVID-19: A cross-sectional study in Malaysia
Mohamad, E. M., Azlan, A. A., Hamzah, M. R., Tham, J. S., Ayub, S. H.
10.1101/2020.04.29.20085563 — Posted: 2020-05-05
A systematic review to evaluate the clinical outcomes in COVID -19 patients on angiotensin converting enzyme inhibitors or angiotensin receptor blockers
Grover, A., Oberoi, M.
10.1101/2020.04.29.20085787 — Posted: 2020-05-05
Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: an Exploratory Randomized, Controlled Trial
Lou, Y., Liu, L., Qiu, Y.
10.1101/2020.04.29.20085761 — Posted: 2020-05-05 Discussion: Onsite
Cross-talk between the airway epithelium and activated immune cells defines severity in COVID-19
Chua, R. L., Lukassen, S., Trump, S., Hennig, B. P., Wendisch, D., Pott, F., Debnath, O., Thürmann, L., Kurth, F., Kazmierski, J., Timmermann, B., Twardziok, S., Schneider, S., Machleidt, F., Müller-Redetzky, H., Krannich, A., Schmidt, S., Balzer, F., Liebig, J., Loske, J., Eils, J., Ishaque, N., von Kalle, C., Hocke, A., Witzenrath, M., Goffinet, C., Drosten, C., Laudi, S., Lehmann, I., Conrad, C., Sander, L.-E., Eils, R.
10.1101/2020.04.29.20084327 — Posted: 2020-05-05 Discussion: Onsite | Offsite
Simple ventilators for emergency use based on Bag-Valve pressing systems: Lessons learned and future steps
Castro-Camus, E., Ornik, J., Mach, C., Hernandez-Cardoso, G. G., Savalia, B., Taiber, J., Ruiz-Marquez, A., Kesper, K., Konde, S., Sommer, C., Wiener, J., Geisel, D., Huppe, F., Kraling, G., Nguyen, J., Wiesmann, T., Beutel, B., Koch, M.
10.1101/2020.04.29.20084749 — Posted: 2020-05-05
The Utility of rRT-PCR in Diagnosis and Assessment of Case-fatality rates of COVID-19 In the Iranian Population. Positive Test Results are a Marker for Illness Severity
Janbabaei, G., Brandt, E. J., Golpira, R., Raeisi, A., Sadegh Tabrizi, J., Safikhani, H. R., Talebian, M. T., Mirab Samiee, S., Biglar, A., Malekzadeh, R., Mani, A.
10.1101/2020.04.29.20085233 — Posted: 2020-05-05
Antibody Profiling and Prevalence in the US population during the SARS-CoV2 Pandemic
Krishnamurthy, H. K., Jayaraman, V., Krishna, K., Rajasekaran, K. E., Wang, T., Bei, K., Rajasekaran, J. J., Yaskin, I., Rai, A. J., Choung, R. S., Murray, J. A.
10.1101/2020.04.29.20085068 — Posted: 2020-05-05 Discussion: Onsite
How many lives can be saved? A global view on the impact of testing, herd immunity and demographics on COVID-19 fatality rates
Sanchez-Romero, M., di Lego, V., Prskawetz, A., L Queiroz, B.
10.1101/2020.04.29.20084400 — Posted: 2020-05-05
Group testing for SARS-CoV-2 allows for up to 10-fold efficiency increase across realistic scenarios and testing strategies
Verdun, C. M., Fuchs, T., Harar, P., Elbrächter, D., Fischer, D. S., Berner, J., Grohs, P., Theis, F. J., Krahmer, F.
10.1101/2020.04.30.20085290 — Posted: 2020-05-05 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).